| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2802548 | Growth Hormone & IGF Research | 2015 | 8 Pages |
Abstract
The marked differences in IGF and IGFBP levels between patients with HCC, liver cirrhosis and healthy subjects are mainly explained by variations in liver status. Therefore, this study questions the clinical utility of circulating IGF variables as markers of HCC.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Ulrick Espelund, Henning Grønbæk, Gerda Elisabeth Villadsen, Kira Simonsen, Poul Frølund Vestergaard, Jens Otto Lunde Jørgensen, Allan Flyvbjerg, Hendrik Vilstrup, Jan Frystyk,